Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE3
Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis
- Status
- COMPLETED
- Phase
- PHASE2
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Rituximab Treatment of Focal Segmental Glomerulosclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- Status
- COMPLETED
- Phase
- NA
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2